This text is a result of machine translation.
Excess PV silicon? Industry: the development of large-size silicon wafers exceeds expectations, and the supply is still tight
Jiangsu Hengrui, Chinese Cancer Drugmaker Emerging from the Shadows
A flagship in the Chinese oncology market, Jiangsu Hengrui Medicine (600276:SH) was accused of corruption in sales. This was soon followed by good news – an approval of a Phase III clinical test. Will a bright future erase the black stain?
May 22, 2020 10:52 PM
Huzhou: there is no time limit for non registered residence residents to continuously pay social security when purchasing houses in central cities
The price of new n-type monocrystalline silicon wafer of Zhonghuan Co., Ltd. is 6% higher than that of p-type silicon wafer with the same thickness
Taier shares: the contract dispute case against Cao Linbin was accepted by the court
Luyang energy conservation: the controlling shareholder plans to suspend the trading of shares in major events
Unpacking China | Key Chinese Firms to Watch This Week (03/05/2026-09/05/2026)
Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.
May 08, 2026 05:58 PM
Yunnan Baiyao's Revenue Rises 33%; Net Profit Falls 40% in 1Q 2021
On April 27, Yunnan Baiyao released a report for the first quarter of 2021 showing that the company's total operating revenue for the first quarter was 10.33 billion yuan, up 33.4% year-on-year; its operating profit was 880 million yuan, down 41.8% year-on-year; its net profit attributable to shareholders of the listed company was 760 million yuan.
Apr 30, 2021 02:07 AM
The annual report is superimposed on the first quarterly report, and the highlights of listed companies are frequent
Central Co., Ltd. comprehensively raised the price of p-type monocrystalline silicon wafer
Yunnan Baiyao: An Oriental Mystery in the Limelight (2/2)
Tagged as ‘China’s Time-honored Brand,’ Traditional Chinese Medicine (TCM) company Yunnan Baiyao (000538:SZ) has come to an unprecedented crossroads after fulfilling the challenge of pushing TCM to the foreground.
May 19, 2020 12:30 PM
Yunnan Baiyao: An Oriental Mystery in the Limelight (1/2)
Tagged as ‘China’s Time-honored Brand,’ Traditional Chinese Medicine (TCM) company Yunnan Baiyao (000538:SZ) has come to an unprecedented crossroads after fulfilling the challenge of pushing TCM to the foreground.
May 19, 2020 12:00 PM
The Commerce Department said the shortage of chips would continue for at least six months
Another Chinese EV Startup Turns Profitable in China’s RMB 5 Trillion Auto Market
May 06, 2026 12:05 PM
AIFC Governor Renat Bekturov: Kazakhstan Is the Gateway for Chinese Capital Moving West
Apr 30, 2026 03:33 PM